Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices
NHS hospitals in England used £303,356,155 of indicative cost of Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 1.2% of all hospital medicines spend. That is down 38.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Adalimumab 40mg/0.8ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Norfolk & Norwich University Hpl Nhs Trt | £13,080,081 |
| Oxford University Hospitals Nhs Ft | £11,512,940 |
| Royal Free London Nhs Foundation Trust | £10,885,902 |
| South Tees Hosp Nhs Foundation Trust | £10,849,693 |
| Royal Cornwall Hospitals Nhs Trust | £10,535,794 |
| Univ Hpl B/Ham Nhs Foundation Trust | £9,576,323 |
| University Hospitals Plymouth Nhs Trust | £9,249,663 |
| Salford Royal Nhs Foundation Trust | £8,961,621 |
| Imperial College Healthcare Nhs Trust | £8,762,740 |
| University Hospitals Dorset Nhs Ft | £7,582,253 |
The primary-care picture
Adalimumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Adalimumab medicine page.